Medicus Pharma Ltd.
MDCX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.51M | -13.97M | -10.57M | -9.68M | -9.68M |
| Total Depreciation and Amortization | -52.10K | -52.10K | -52.10K | 26.30K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 786.60K | 1.03M | 959.80K | -195.80K | 1.13M |
| Change in Net Operating Assets | 32.90K | -60.40K | -622.60K | -563.00K | 1.06M |
| Cash from Operations | -15.75M | -13.05M | -10.29M | -10.41M | -7.49M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 4.50M | 5.17M | 5.17M | 5.17M | 5.17M |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -35.00K | -- |
| Issuance of Common Stock | 12.82M | 11.30M | 7.52M | 5.47M | 10.58M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -311.80K | 15.60K | 40.60K | 0.00 | -- |
| Cash from Financing | 17.01M | 16.49M | 12.73M | 10.61M | 15.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.26M | 3.44M | 2.44M | 197.30K | 8.26M |